Satter Management

Latest statistics and disclosures from Alerce Investment Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ANNX, AKBA, AMWL, ALRN, AADI, and represent 100.00% of Alerce Investment Management's stock portfolio.
  • Reduced shares in these 1 stock: AKBA (-$5.5M).
  • Alerce Investment Management was a net seller of stock by $-5.5M.
  • Alerce Investment Management has $95M in assets under management (AUM), dropping by 26.52%.
  • Central Index Key (CIK): 0001844002

Tip: Access up to 7 years of quarterly data

Positions held by Satter Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Alerce Investment Management

Alerce Investment Management holds 5 positions in its portfolio as reported in the March 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Annexon (ANNX) 55.8 $53M 7.4M 7.17
 View chart
Akebia Therapeutics (AKBA) 25.4 $24M -18% 13M 1.83
 View chart
American Well Corp Cl A (AMWL) 8.9 $8.5M 11M 0.81
 View chart
Aileron Therapeutics Com New (ALRN) 5.8 $5.5M 831k 6.63
 View chart
Aadi Bioscience (AADI) 4.0 $3.8M 1.6M 2.34
 View chart

Past Filings by Alerce Investment Management

SEC 13F filings are viewable for Alerce Investment Management going back to 2020